That's exactly why it is too cheap at 11c , this would be a floor and should rebound from here. IMO
Roths have done the analysis. You don't get a more detailed analysis than that.... They are raising their price target to 20c "as a result of the robust efficacy in the absence of any additional safety concerns due to inclusion of HER-Vaxxx." Its done very well in the interim trials and look at the professional scientific credentials of the board. Amazing.
Its a no brainer. STRONG BUY.
-
- There are more pages in this discussion • 5,862 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $338.0K | 30.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 3480808 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 10994115 | 28 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |